Portfolio company
Genorare
Netherlands
Raised
Undisclosed
Latest stage
Pre-seed
Rounds recorded
1 · 1 undisclosed
Backed by
1 investor
Sectors
About
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
SourceFunding history · 1
Similar companies
GenMD
The company develops an anonymised synthetic health data platform for pharmaceutical companies, academic researchers and healthcare systems to share medical records securely.
Nostos Genomics
The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.
Galeon
This company develops blockchain-secured electronic health record software for hospitals and medical researchers to manage patient data and train artificial intelligence models.
FDNA
This company develops artificial intelligence phenotyping software to help clinicians and researchers identify rare diseases and genetic disorders in patients.
Citizen Health
This company develops a data platform that aggregates medical records and provides AI-driven health insights for patients with rare and complex conditions.
TMA Precision Health
This company provides a clinical decision support platform using genomic data and medical records to improve rare disease diagnosis for health systems and pharmaceutical partners.
Nerai
This company develops specific genome editors using an artificial intelligence protein discovery platform for biotechnology firms and patients with rare inherited diseases.
Secure AI Labs
This company provides a federated learning platform for hospitals and researchers to analyse sensitive healthcare data without compromising patient privacy.
